GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	6.39B +107.2%
Revenue (ttm)	3.73B +24.7%
Net Income	213.23M +22.6%
EPS	2.55 +22.6%
Shares Out	83.51M
PE Ratio	29.97
Forward PE	n/a
Dividend	1.00 (1.31%)
Ex-Dividend Date	Jan 12, 2026

Volume	253,433
Average Volume	156,503
Open	76.22
Previous Close	76.22
Day's Range	76.20 - 79.99
52-Week Range	34.34 - 81.50
Beta	0.81
RSI	83.31
Earnings Date	May 18, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.